Don't Miss ISPE's CEO Night on February 19th!

Interested in the latest developments and trends in the local Bay Area biotech hub, and why it’s such a hot market for these novel biotechnologies? We’ll be exploring all this and more, including what this means for new, emerging technologies, and how this impacts the market, as well as the young, modern bay area work force. 

Register now to learn more from Alison Moore, CTO of Allogene Therapeutics, Robert Kiss, VP of Process and Analytical Development at Sutro Biopharma, Inc., and Kathy Yi, CFO of Sangamo Therapeutics, Inc., who will be sharing their personal stories and insights about the state of the industry.  We look forward to seeing you all there!

ISPE SF CEO Night.png